Resultados de procura - Danilo Fliser

Limitar resultados
  1. 1
    Clinical relevance of FGF-23 in chronic kidney disease

    Clinical relevance of FGF-23 in chronic kidney disease por Sarah Seiler, Gunnar H. Heine, Danilo Fliser

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Calcium and phosphate impact cardiovascular risk

    Calcium and phosphate impact cardiovascular risk por Gunnar H. Heine, Masaomi Nangaku, Danilo Fliser

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    FGF-23: the rise of a novel cardiovascular risk marker in CKD

    FGF-23: the rise of a novel cardiovascular risk marker in CKD por Gunnar H. Heine, Sarah Seiler, Danilo Fliser

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure

    Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure por Danilo Fliser, M. Schröter, Monika Neubeck, Eberhard Ritz

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Innate immunity in CKD-associated vascular diseases

    Innate immunity in CKD-associated vascular diseases por Stephen Zewinger, Timo Schumann, Danilo Fliser, Thimoteus Speer

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Renal functional reserve in healthy elderly subjects.

    Renal functional reserve in healthy elderly subjects. por Danilo Fliser, M. Zeier, Rainer Nowack, Eberhard Ritz

    Publicado 1993
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Renal findings in patients with short-term type 2 diabetes.

    Renal findings in patients with short-term type 2 diabetes. por Christine K. Keller, K. Bergis, Danilo Fliser, Eberhard Ritz

    Publicado 1996
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Cardiovascular Disease in Chronic Kidney Disease

    Cardiovascular Disease in Chronic Kidney Disease por Joachim Jankowski, Jürgen Floege, Danilo Fliser, Michael Böhm, Nikolaus Marx

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease

    Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease por Christof Ulrich, Gunnar H. Heine, Eric Seibert, Danilo Fliser, Matthias Girndt

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes

    Chronic Angiotensin II Receptor Blockade Reduces (Intra)Renal Vascular Resistance in Patients with Type 2 Diabetes por Danilo Fliser, Kathrin-Kristin Wagner, Astrid Loos, Dimitrios Tsikas, Hermann Haller

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Renal function in the elderly: Impact of hypertension and cardiac function

    Renal function in the elderly: Impact of hypertension and cardiac function por Danilo Fliser, Edward Franek, Markus Joest, Stefan Block, Ernst Mutschler, Eberhard Ritz

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis

    Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis por Sascha David, P. Kumpers, V. Seidler, Frank Biertz, Hermann Haller, Danilo Fliser

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Lipoproteins in chronic kidney disease: from bench to bedside

    Lipoproteins in chronic kidney disease: from bench to bedside por Thimoteus Speer, Paul M. Ridker, Arnold von Eckardstein, Stefan Schunk, Danilo Fliser

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

    FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment por Sarah Seiler, B Reichart, Daniel Röth, Eric Seibert, Danilo Fliser, Gunnar H. Heine

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction

    Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction por Matthias Klingele, Theresa Stadler, Danilo Fliser, Thimoteus Speer, Heinrich V. Groesdonk, Alexander Raddatz

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study

    Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study por Barbara Kollerits, Danilo Fliser, Iris M. Heid, Eberhard Ritz, Florian Kronenberg, for the MMKD Study Group

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Stimulation of Endothelial Progenitor Cells

    Stimulation of Endothelial Progenitor Cells por Ferdinand H. Bahlmann, Kirsten de Groot, Ottfried Mueller, Barbara Hertel, Hermann Haller, Danilo Fliser

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Coadministration of albumin and furosemide in patients with the nephrotic syndrome

    Coadministration of albumin and furosemide in patients with the nephrotic syndrome por Danilo Fliser, Ines Zurbrüggen, E. Mutschler, Irene Bischoff, Jürg Nussberger, Edward Franek, Eberhard Ritz

    Publicado 1999
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

    Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis por Jan T. Kielstein, Shelley R. Salpeter, Stefanie M. Bode-Boeger, John P. Cooke, Danilo Fliser

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease

    Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease por Bjoern Becker, Florian Kronenberg, Jan T. Kielstein, Hermann Haller, Christian Morath, Eberhard Ritz, Danilo Fliser

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: